文献速递妇科

腹腔镜与机器人手术治疗子宫内膜癌的围手术期恢复与麻醉药使用比较

Perioperative Recovery and Narcotic Use in Laparoscopic versus Robotic Surgery for Endometrial Cancer.
PubMed 文献 · J Minim Invasive Gynecol · 2021-05-07

该回顾性队列研究比较了2018年1月至2019年7月期间接受微创手术的子宫内膜癌患者,其中腹腔镜139例、机器人101例。结果显示两组围手术期麻醉药用量无差异,但机器人组恢复室时间和手术时间更长,且当日出院率更低,但多因素分析中手术方式并非当日出院的预测因素。

要点

  • 腹腔镜与机器人手术的围手术期麻醉药用量无显著差异
  • 机器人手术恢复室时间和手术时间更长,但多因素分析无差异
  • 机器人组当日出院率更低,可能与医生选择有关

核心结论

  • 机器人手术与腹腔镜手术在围手术期麻醉药使用上无差异
  • 机器人手术恢复时间更长,但多因素分析中不显著
  • 机器人手术当日出院率更低,可能与医生选择而非手术方式有关

研究设计与样本

  • 回顾性队列研究,纳入20个月内接受微创手术的子宫内膜癌患者
  • 腹腔镜139例,机器人101例
  • 数据来自医院账单记录,收集麻醉药用量(换算为静脉吗啡毫克当量)、恢复室时间和住院时间

主要发现

  • 两组在失血量、酒精使用和吸烟方面无差异
  • 腹腔镜组体重指数显著低于机器人组(32.9 vs 38.0 kg/m2;p <.001)
  • 单因素分析显示两组术中麻醉药用量无差异(21.7 vs 21.1 MME;p = .64)
  • 机器人组恢复室时间更长(163分钟 vs 128分钟;p <.001),手术时间更长(288分钟 vs 204分钟;p = .001)
  • 机器人组更常行全淋巴结清扫(38.0% vs 20.8%;p <.001)

关键数值与推荐

  • 多因素分析中预测总麻醉药用量的显著因素为年龄、术前加速康复外科方案使用和手术时间
  • 多因素分析中手术方式并非当日出院的预测因素

临床怎么用

  • 机器人手术并未增加围手术期麻醉药用量,但恢复时间和手术时间较长
  • 当日出院率差异可能与医生选择有关,需进一步评估出院标准

局限性

  • 回顾性设计,可能存在选择偏倚
  • 两组体重指数存在显著差异,可能影响结果
  • 未报告其他潜在混杂因素

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To compare intraoperative and perioperative narcotic use, recovery room time, and total hospital stay for patients treated with robotic vs laparoscopic surgery for endometrial cancer. DESIGN: Retrospective cohort. SETTING: Teaching hospital. PATIENTS: All patients having minimally invasive surgery in the division of gynecologic oncology during a 20-month period. INTERVENTION: Laparoscopic cases were compared with robot-assisted cases with respect to perioperative outcome. MEASUREMENT AND MAIN RESULTS: Hospital billing records were used to identify all patients with endometrial cancer treated from January 1, 2018 through July 31, 2019 undergoing either laparoscopic or robotic surgery. Data were collected including total narcotic use converted to intravenous morphine milligram equivalent (MME), total amount of time in recovery, and length of hospital stay. A total of 139 laparoscopic and 101 robotic surgeries were eligible for analysis. There was no difference between the groups with respect to blood loss, alcohol use, or smoking. Patients undergoing laparoscopy had a significantly lower body mass index compared with patients undergoing robotic surgery (32.9 vs 38.0 kg/m2; p <.001). Univariate analysis showed no difference between the 2 groups with respect to narcotic use in surgery (21.7 vs 21.1 MME; p = .64), recovery (4.3 vs 4.5 MME; p = .70), or total dose (26.0 vs 25.6 MME; p = .78). However, patients who underwent a robotic approach had a longer recovery room time (128 minutes vs 163 minutes; p <.001 and a longer surgical time (288 minutes vs 204 minutes; p = .001). Patients in the robotic group were also more likely to undergo full lymphadenectomy than patients in the laparoscopy group (38.0% vs 20.8% p <.001). In a multivariate analysis, the only significant factors for predicting total narcotic dose were age, use of a preoperative enhanced recovery after surgery program, and surgical time. Patients who had laparoscopy were more likely to achieve same-day discharge (39.3% vs 17.8%; p <.001), but in the multivariate analysis, the type of surgery did not predict same-day discharge. CONCLUSION: There was no difference in narcotic use in the perioperative period with robotic surgery compared with laparoscopy. Recovery time was longer for robotic surgery, but this was not significant in multivariate analysis. Same-day discharges were less frequent with robotics, which may be more related to the physician's choice rather than the procedure.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Crane EK, Brown J, Lehman A, et al. Perioperative Recovery and Narcotic Use in Laparoscopic versus Robotic Surgery for Endometrial Cancer. J Minim Invasive Gynecol. 2021. PMID: 33965644. doi:10.1016/j.jmig.2021.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。